Johnston's most recent trade in Microsoft Corporation was a trade of 2 Restricted Stock Units done . Disclosure was reported to the exchange on March 13, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Microsoft Corporation | Hugh F. Johnston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 2 | 975 | - | - | Restricted Stock Units | |
Aware Inc. | Brent P. Johnstone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 54,698 | 54,698 | - | - | Unrestricted Stock Award | |
Cincinnati Financial Corp. | Steven J. Johnston | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 4,132 | 192,835 (0%) | 0% | 0 | Common Stock | |
Cincinnati Financial Corp. | Steven J. Johnston | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 4,131 | 0 | - | - | Performance Stock Units | |
Cincinnati Financial Corp. | Steven J. Johnston | Director, Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 146.60 per share. | 03 Mar 2025 | 1,820 | 191,676 (0%) | 0% | 146.6 | 266,812 | Common Stock |
Cincinnati Financial Corp. | Steven J. Johnston | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 931 | 194,566 (0%) | 0% | 0 | Common Stock | |
Cincinnati Financial Corp. | Steven J. Johnston | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 931 | 1,861 | - | - | Restricted Stock Units | |
Cincinnati Financial Corp. | Steven J. Johnston | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 800 | 193,635 (0%) | 0% | 0 | Common Stock | |
Cincinnati Financial Corp. | Steven J. Johnston | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 800 | 801 | - | - | Restricted Stock Units | |
Cincinnati Financial Corp. | Steven J. Johnston | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 765 | 188,703 (0%) | 0% | 0 | Common Stock | |
Cincinnati Financial Corp. | Steven J. Johnston | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 765 | 0 | - | - | Restricted Stock Units | |
Cincinnati Financial Corp. | Steven J. Johnston | Director, Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 146.60 per share. | 03 Mar 2025 | 399 | 193,824 (0%) | 0% | 146.6 | 58,493 | Common Stock |
Cincinnati Financial Corp. | Steven J. Johnston | Director, Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 146.60 per share. | 03 Mar 2025 | 343 | 194,223 (0%) | 0% | 146.6 | 50,284 | Common Stock |
Cincinnati Financial Corp. | Steven J. Johnston | Director, Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 146.60 per share. | 03 Mar 2025 | 328 | 193,496 (0%) | 0% | 146.6 | 48,085 | Common Stock |
Intel Corp. | Michelle Johnston Holthaus | Interim Co-CEO, CEO Intel Prod | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 359,304 | 359,304 | - | - | Restricted Stock Units | |
Intel Corp. | Michelle Johnston Holthaus | Interim Co-CEO, CEO Intel Prod | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 359,304 | 359,304 | - | - | Performance Stock Units | |
Intel Corp. | Michelle Johnston Holthaus | Interim Co-CEO, CEO Intel Prod | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 224,565 | 224,565 | - | - | Restricted Stock Units | |
Brandywine Realty Trust | George D. Johnstone | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 94,262 | 542,891 (0%) | 0% | 0 | Common Shares of Beneficial Interest | |
Intel Corp. | Michelle Johnston Holthaus | Interim Co-CEO, CEO Intel Prod | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 32,389 | 362,592 (0%) | 0% | - | Common Stock | |
Intel Corp. | Michelle Johnston Holthaus | Interim Co-CEO, CEO Intel Prod | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 32,389 | 64,789 | - | - | Restricted Stock Units | |
Intel Corp. | Michelle Johnston Holthaus | Interim Co-CEO, CEO Intel Prod | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.54 per share. | 28 Feb 2025 | 11,483 | 351,109 (0%) | 0% | 23.5 | 270,310 | Common Stock |
Brandywine Realty Trust | George D. Johnstone | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 28 Feb 2025 | 2,215 | 540,676 (0%) | 0% | 4.9 | 10,809 | Common Shares of Beneficial Interest |
Terex Corp. | Stephen Johnston | VP CAO and Controller | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2025 | 387 | 14,312 (0%) | 0% | 0 | Common Stock, $.01 par value | |
Cushman & Wakefield plc | Neil O. Johnston | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 92,437 | 92,437 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Neil O. Johnston | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 22,882 | 199,533 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | Neil O. Johnston | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.01 per share. | 26 Feb 2025 | 6,806 | 192,727 (0%) | 0% | 12.0 | 81,740 | Ordinary Shares |
Cushman & Wakefield plc | Neil O. Johnston | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2025 | 27,404 | 173,690 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | Neil O. Johnston | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2025 | 27,404 | 27,405 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Neil O. Johnston | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2025 | 16,334 | 0 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Neil O. Johnston | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2025 | 16,334 | 181,509 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | Neil O. Johnston | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.64 per share. | 23 Feb 2025 | 8,515 | 165,175 (0%) | 0% | 11.6 | 99,115 | Ordinary Shares |
Cushman & Wakefield plc | Neil O. Johnston | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.74 per share. | 23 Feb 2025 | 4,858 | 176,651 (0%) | 0% | 11.7 | 57,033 | Ordinary Shares |
Cincinnati Financial Corp. | Steven J. Johnston | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2025 | 17,576 | 17,576 | - | - | Stock Option (Right to Buy) | |
Cincinnati Financial Corp. | Steven J. Johnston | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2025 | 11,260 | 11,260 | - | - | Performance Stock Units | |
Cincinnati Financial Corp. | Steven J. Johnston | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2025 | 939 | 939 | - | - | Restricted Stock Units | |
Howard Hughes Holdings Inc | Douglas Johnstone | Regional President, Hawaii | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 3,952 | 15,414 (0%) | 0% | 0 | Common stock, $0.01 par value per share | |
Howard Hughes Holdings Inc | Douglas Johnstone | Regional President, Hawaii | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 3,952 | 19,366 (0%) | 0% | 0 | Common stock, $0.01 par value per share | |
Brandywine Realty Trust | George D. Johnstone | EVP, Operations | Grant, award, or other acquisition of securities at price $ 5.49 per share. | 31 Jan 2025 | 44,158 | 460,882 (0%) | 0% | 5.5 | 242,427 | Common Shares of Beneficial Interest |
Brandywine Realty Trust | George D. Johnstone | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.49 per share. | 31 Jan 2025 | 24,776 | 436,106 (0%) | 0% | 5.5 | 136,020 | Common Shares of Beneficial Interest |
Brandywine Realty Trust | George D. Johnstone | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 17,043 | 453,149 (0%) | 0% | 0 | Common Shares of Beneficial Interest | |
Brandywine Realty Trust | George D. Johnstone | EVP, Operations | Grant, award, or other acquisition of securities at price $ 5.49 per share. | 31 Jan 2025 | 8,522 | 444,628 (0%) | 0% | 5.5 | 46,786 | Common Shares of Beneficial Interest |
Intel Corp. | Michelle Johnston Holthaus | Interim Co-CEO, CEO Intel Prod | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 8,118 | 331,389 (0%) | 0% | - | Common Stock | |
Intel Corp. | Michelle Johnston Holthaus | Interim Co-CEO, CEO Intel Prod | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 8,118 | 0 | - | - | Restricted Stock Units | |
Brandywine Realty Trust | George D. Johnstone | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.49 per share. | 31 Jan 2025 | 4,520 | 448,629 (0%) | 0% | 5.5 | 24,815 | Common Shares of Beneficial Interest |
Brandywine Realty Trust | George D. Johnstone | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.49 per share. | 31 Jan 2025 | 4,319 | 440,309 (0%) | 0% | 5.5 | 23,711 | Common Shares of Beneficial Interest |
Intel Corp. | Michelle Johnston Holthaus | Interim Co-CEO, CEO Intel Prod | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.86 per share. | 31 Jan 2025 | 2,003 | 329,386 (0%) | 0% | 19.9 | 39,780 | Common Stock |
Microsoft Corporation | Hugh F. Johnston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 252 | 973 | - | - | Restricted Stock Units | |
Healthpeak Properties Inc. | Shawn G. Johnston | EVP and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 11,658 | 11,658 | - | - | LTIP Units | |
Healthpeak Properties Inc. | Shawn G. Johnston | EVP and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 6,709 | 6,709 | - | - | LTIP Units | |
Howard Hughes Holdings Inc | Douglas Johnstone | Regional President, Hawaii | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.88 per share. | 30 Jan 2025 | 403 | 11,462 (0%) | 0% | 76.9 | 30,983 | Common stock, $0.01 par value per share |
MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.93 per share. | 27 Jan 2025 | 3,000 | 144,950 | - | 2.9 | 8,796 | Common Stock |
MaxCyte Inc | John Joseph Johnston | Director | Sale of securities on an exchange or to another person at price $ 4.64 per share. | 27 Jan 2025 | 3,000 | 141,950 | - | 4.6 | 13,935 | Common Stock |
MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 3,000 | 17,417 | - | - | Stock Option (right to buy) | |
MaxCyte Inc | John Joseph Johnston | Non-Executive Director | 27 Jan 2025 | 3,000 | 123,583 (0%) | 0% | 2.9 | 8,796 | Ords 0.01p | |
MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.67 per share. | 27 Jan 2025 | 1,300 | 120,883 (0%) | 0% | 4.7 | 6,071 | Ords 0.01p |
MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.66 per share. | 27 Jan 2025 | 500 | 122,183 (0%) | 0% | 4.7 | 2,330 | Ords 0.01p |
MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.60 per share. | 27 Jan 2025 | 300 | 122,883 (0%) | 0% | 4.6 | 1,380 | Ords 0.01p |
MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.53 per share. | 27 Jan 2025 | 200 | 123,283 (0%) | 0% | 4.5 | 906 | Ords 0.01p |
MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.64 per share. | 27 Jan 2025 | 200 | 122,683 (0%) | 0% | 4.6 | 928 | Ords 0.01p |
MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.52 per share. | 27 Jan 2025 | 100 | 123,483 (0%) | 0% | 4.5 | 452 | Ords 0.01p |
MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.56 per share. | 27 Jan 2025 | 100 | 123,183 (0%) | 0% | 4.6 | 456 | Ords 0.01p |
MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.69 per share. | 27 Jan 2025 | 100 | 120,783 (0%) | 0% | 4.7 | 469 | Ords 0.01p |
MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.70 per share. | 27 Jan 2025 | 100 | 120,683 (0%) | 0% | 4.7 | 470 | Ords 0.01p |
MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.72 per share. | 27 Jan 2025 | 100 | 120,583 (0%) | 0% | 4.7 | 472 | Ords 0.01p |
Summit Midstream Corp. | James David Johnston | Executive VP, GC, CCO and Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2025 | 10,795 | 38,996 (0%) | 0% | - | Common Stock | |
Summit Midstream Corp. | James David Johnston | Executive VP, GC, CCO and Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2025 | 10,795 | 91,950 | - | - | Corporation Restricted Stock Units | |
Summit Midstream Corp. | James David Johnston | Executive VP, GC, CCO and Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.57 per share. | 18 Jan 2025 | 2,811 | 36,185 (0%) | 0% | 41.6 | 116,853 | Common Stock |
Walt Disney Co (The) | Hugh F. Johnston | SEVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 80,490 | 80,490 | - | - | Stock Option (Right-to-Buy) | |
Walt Disney Co (The) | Hugh F. Johnston | SEVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 28,150 | 28,150 | - | - | Restricted Stock Unit | |
Exponent Inc. | Paul R. Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.45 per share. | 03 Jan 2025 | 5,700 | 65,106 (0%) | 0% | 37.5 | 213,465 | Common Stock |
Exponent Inc. | Paul R. Johnston | Director | Sale of securities on an exchange or to another person at price $ 95.41 per share. | 03 Jan 2025 | 5,700 | 59,406 (0%) | 0% | 95.4 | 543,847 | Common Stock |
Exponent Inc. | Paul R. Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 5,700 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Aware Inc. | Brent P. Johnstone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 18,240 | 216,955 (1%) | 0% | 0 | Common Stock | |
Howard Hughes Holdings Inc | Douglas Johnstone | Regional President, Hawaii | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.92 per share. | 31 Dec 2024 | 861 | 11,865 (0%) | 0% | 76.9 | 66,228 | Common stock, $0.01 par value per share |
MaxCyte Inc | John Johnston Joseph | Director | Sale of securities on an exchange or to another person at price $ 4.01 per share. | 26 Dec 2024 | 3,000 | 141,950 | - | 4.0 | 12,021 | Common Stock |
MaxCyte Inc | Joseph Johnston John | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.93 per share. | 26 Dec 2024 | 3,000 | 144,950 | - | 2.9 | 8,796 | Common Stock |
MaxCyte Inc | Johnston John Joseph | Non-Executive Director | 26 Dec 2024 | 3,000 | 123,583 (0%) | 0% | 2.9 | 8,796 | Ords 0.01p | |
MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Dec 2024 | 3,000 | 20,417 | - | - | Stock Option (right to buy) | |
MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 26 Dec 2024 | 1,431 | 121,942 (0%) | 0% | 4 | 5,724 | Ords 0.01p |
MaxCyte Inc | Johnston John Joseph | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.01 per share. | 26 Dec 2024 | 300 | 121,392 (0%) | 0% | 4.0 | 1,203 | Ords 0.01p |
MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 26 Dec 2024 | 210 | 123,373 (0%) | 0% | 4.0 | 839 | Ords 0.01p |
MaxCyte Inc | Joseph John Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.02 per share. | 26 Dec 2024 | 200 | 120,792 (0%) | 0% | 4.0 | 804 | Ords 0.01p |
MaxCyte Inc | Joseph Johnston John | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.01 per share. | 26 Dec 2024 | 200 | 121,192 (0%) | 0% | 4.0 | 802 | Ords 0.01p |
MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.02 per share. | 26 Dec 2024 | 200 | 120,992 (0%) | 0% | 4.0 | 803 | Ords 0.01p |
MaxCyte Inc | Joseph John Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 26 Dec 2024 | 200 | 121,742 (0%) | 0% | 4 | 800 | Ords 0.01p |
MaxCyte Inc | Joseph Johnston John | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.03 per share. | 26 Dec 2024 | 153 | 120,639 (0%) | 0% | 4.0 | 617 | Ords 0.01p |
MaxCyte Inc | John Johnston Joseph | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.05 per share. | 26 Dec 2024 | 56 | 120,583 (0%) | 0% | 4.1 | 227 | Ords 0.01p |
MaxCyte Inc | John Joseph Johnston | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 26 Dec 2024 | 50 | 121,692 (0%) | 0% | 4 | 200 | Ords 0.01p |
Walt Disney Co (The) | Hugh F. Johnston | SEVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 12,548 | 12,578 (0%) | 0% | - | Disney Common Stock | |
Walt Disney Co (The) | Hugh F. Johnston | SEVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 12,548 | 25,097 | - | - | Restricted Stock Unit | |
Walt Disney Co (The) | Hugh F. Johnston | SEVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 114.13 per share. | 15 Dec 2024 | 5,801 | 6,777 (0%) | 0% | 114.1 | 662,068 | Disney Common Stock |
Summit Midstream Corp. | David James Johnston | Executive VP, GC, CCO and Secy | Sale of securities on an exchange or to another person at price $ 36.20 per share. | 12 Dec 2024 | 20,000 | 28,201 (0%) | 0% | 36.2 | 724,000 | Common Stock |
Microsoft Corporation | Hugh F. Johnston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 1 | 720 | - | - | Restricted Stock Units | |
Microsoft Corporation | Hugh F. Johnston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 227 | 719 | - | - | Restricted Stock Units | |
MaxCyte Inc | John Joseph Johnston | Director | Sale of securities on an exchange or to another person at price $ 3.79 per share. | 06 Dec 2024 | 2,495 | 141,950 | - | 3.8 | 9,459 | Common Stock |
MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 1,121 | 0 | - | - | Stock Option (right to buy) | |
MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 06 Dec 2024 | 1,121 | 143,962 | - | 1.6 | 1,840 | Common Stock |
MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 891 | 0 | - | - | Stock Option (right to buy) | |
MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.93 per share. | 06 Dec 2024 | 891 | 142,841 | - | 2.9 | 2,607 | Common Stock |
MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.93 per share. | 06 Dec 2024 | 505 | 142,455 | - | 2.9 | 1,478 | Common Stock |
MaxCyte Inc | John Joseph Johnston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 505 | 891 | - | - | Stock Option (right to buy) |